US regulatory officials say they have identified not one but two supposed generic copies of the attention deficit hyperactive disorder (ADHD) treatment drug Concerta that have failed to demonstrate ...

An internal US Food and Drug Administration (FDA) re-examination of previously submitted data has raised concerns that two generic medications used to treat attention ...

Many of the ADHD medication shortages that have plagued the U.S. for the last two years have now been resolved, the Food and Drug Administration says. Yet some doctors and patients report they are ...

Several lots of a generic ADHD medication used by millions are under recall because users may not be getting the full benefit. Sun Pharmaceutical Industries issued the voluntary, nationwide recall for ...

A generic attention deficit hyperactive disorder (ADHD) drug manufactured by Mallinckrodt has been found by the US Food and Drug Administration (FDA) to not be sufficiently equivalent to its reference ...

Mylan N.V. (NASDAQ, TASE: MYL), today announced the U.S. launch of Methylphenidate Hydrochloride Extended-Release Tablets USP, 18 mg, 27 mg, 36 mg and 54 mg, a generic version of Janssen's Concerta® ...

Hyderabad-based Granules Pharmaceuticals has received tentative approval from the US Food and Drug Administration (FDA) for its generic Attention Deficit Hyperactivity Disorder (ADHD) medication. The ...

Early drug treatment for ADHD in Sweden was tied to reduced risk of suicidal behavior, substance misuse, transport accidents, and crime. Benefits extended to recurrent events, possibly due to improved ...